Meet us at 5th Antibody Industrial Symposium, June 27-28, Tours – France

McSAF is presenting at the 5th Antibody Industrial Summit, co-organized by MAbDesign, MAbImprove & Polepharma, June 27-28, in Tours, France.

More information & B2B request meeting on … http://ais2017.fr

Meet us at next World ADC Summit, Berlin, 20-22th Feb

McSAF’s team will be attending next World ADC Summit Europe, Berlin, .

World ADC Summit is the main event dedicated to Antibody Drug Conjugates in Europe. More information …

Will be participating :

  • Marie-Claude Viaud-Massuard, Scientific Director
  • David Bonnafous, Chief Operating Officer, in charge of Business Development & Strategic Partnerships,
  • Christine Baltus, R&D Director

Looking forward to seeing you there

Meeting request : contact@mcsaf.fr.

MC Viaud, McSAF CSO, presenting new ADC-linker technologies at Immunoconjugates for Personalised Medicine, Nantes, 9th Feb

Marie-Claud VIAUD-MASSUARD, McSAF Chief Scientific Officer & co-founder will be given a talk on new ADC-linker technologies on next meeting dedicated to “Immunoconjugates for personalised medicine”, co-organized par MAbDesign & Atlanpole Biotherapies – 9th fev. Nantes. More information : https://lnkd.in/d7QZK25

Meet McSAF’s team at next International Partnering Conference BIO-Europe, Koehln, Nov 07-09, 2016

McSAF’s team is pleased to announce its attendance at Bio-Europe from November 7-9, 2016 in Cologne, Germany.
BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry which hosts more than 3,500 professionals and 1,800 companies from over 50 countries. The conference annually attracts leading dealmakers from biotech, pharma and finance.

David Bonnafous, Chief Operating Officer, in charge of Business Development & Strategic Alliances, will attend the conference.
We would be pleased to meet with you during BIO-Europe. To schedule a meeting, please send an email to contact@mcsaf.fr.

We look forward to hearing from you!

McSAF recognized as Young Innovative Company

McSAF recognized as Young Innovative Company, regarding its own R&D programs related to Bioconjugates Chemistry, and specifically Antibody Drug Conjugates (ADCs).

BioTechnoCentre Meeting, oct 13-14th 2016, Domaine de Seillac (41), France.

McSAF will attend & present its activities in next BioTechnoCentre Meeting, oct 13-14th 2016, Domaine de Seillac, France. More information : https://lnkd.in/eXc4VW2

“New chemical and biological tools for targeting in cancer imaging and therapy”, Sept 21-24th 2016, Le Bono – France.

McSAF will attend next meeting dedicated to “New chemical and biological tools for targeting in cancer imaging and therapy”, organized by Cancéropôle Grand Ouest, Sept 21-24th 2016 at Le Bono, France.  https://lnkd.in/eCVyUu2

McSAF Website opening

McSAF is pleased to announced its new website available at www.mcsaf.com

Antibody Industrial Symposium, July 4th-5th2016, Montpellier – France.

McSAF will be participating on next Antibody Industrial Symposium, co-organized by MAbDesign & MAbImprove on July 4th-5th in Montpellier France. Looking forward to seeing you there … https://lnkd.in/eGandTM